About ipratropiu m + uniit
Anticholinergic bronchodilator
Used for
- Relieves bronchospasm in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
- May be used with other inhaled medicines for acute bronchospasm.
Usual adult dose
For nebulized ipratropium alone, the usual dose is 0.5 mg three to four times daily; combination products may differ.
Common side effects
- Dry mouth
- Cough or throat irritation
- Headache or dizziness
- Blurred vision if mist enters the eyes
Important warnings
- Can worsen narrow-angle glaucoma, especially if mist reaches the eyes.
- Use cautiously with an enlarged prostate or difficulty urinating.
- Seek urgent care for sudden worsening breathing or an allergic reaction.
- Not a substitute for emergency treatment of severe breathing attacks.
Pregnancy
Use only when needed after weighing potential benefits and risks; pregnancy data are limited.
Breastfeeding
Low absorption is expected, but breastfeeding safety data are limited; use if clinically needed.
Interactions
- Other anticholinergic medicines may increase side effects.
- Other inhaled bronchodilators can affect breathing, heart rate, or other side effects.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.